Stock Compensation Plans

3 Months Ended

Dec. 31, 2021

Share-based Payment Arrangement, Noncash Expense [Abstract]

STOCK COMPENSATION PLANS

Under the Company’s 2003 Stock Option Plan, the Company was able to grant options for up to 300,000 shares of common stock to employees, officers, directors and directors emeriti. Under the Company's 2014 Equity Incentive Plan, the Company is able to grant options and awards of restricted stock (with or without performance measures) for up to 352,366 shares of common stock to employees, officers, directors and directors emeriti. Under the Company's 2019 Equity Incentive Plan, the Company is able to grant options and awards or restricted stock (with or without performance measures) for up to 350,000 shares of common stock, of which 300,000 shares are reserved to be awarded to employees, including officers, and 50,000 shares are reserved to be awarded to directors and directors emeriti. Shares issued may be purchased in the open market or may be issued from authorized and unissued shares. The exercise price of each option equals the fair market value of the Company’s common stock on the date of grant. Generally, options and restricted stock vest in 20% annual installments on each of the five anniversaries from the date of the grant, and options generally have a maximum contractual term of ten years from the date of grant. At December 31, 2021, there were 21,520 shares of common stock available which may be awarded as options or restricted stock pursuant to future grant under the 2014 Equity Incentive Plan. At December 31, 2021, there were 238,000 shares of common stock available which may be awarded as options or restricted stock pursuant to future grant under the 2019 Equity Incentive Plan.

At both December 31, 2021 and 2020, there were no unvested restricted stock awards. There were no restricted stock grants awarded during the three months ended December 31, 2021 and 2020.

Stock option activity for the three months ended December 31, 2021 and 2020 is summarized as follows:


	Three Months Ended December 31, 2021			Three Months Ended December 31, 2020
	Number of Shares	Weighted Average Exercise Price		Number of Shares	Weighted Average Exercise Price
Options outstanding, beginning of period	406,815	$	21.62	395,349	$	18.45
Exercised	(8,900)	14.63		(9,900)	9.70
Granted	1,000	27.25		1,500	19.13
Forfeited	(11,594)	25.28		(2,320)	26.69
Options outstanding, end of period	387,321	$	21.70	384,629	$	18.62

The fair value of stock options is determined using the Black-Scholes valuation model.

The weighted average assumptions for options granted during the three months ended December 31, 2021 were as follows:


Expected volatility	34		%
Expected life (in years)	5
Expected dividend yield	3.49		%
Risk free interest rate	1.22		%
Grant date fair value per share	$	5.88

The aggregate intrinsic value of options exercised during the three months ended December 31, 2021 and 2020 was $123,000 and $120,000, respectively.

At December 31, 2021, there were 176,670 unvested options with an aggregate grant date fair value of $844,000, all of which the Company assumes will vest. The aggregate intrinsic value of unvested options at December 31, 2021 was $568,000. There were 200 options vested during the three months ended December 31, 2021 with a total fair value of $1,000.

At December 31, 2020, there were 158,572 unvested options with an aggregate grant date fair value of $567,000. There were 200 options that vested during the three months ended December 31, 2020.

Additional information regarding options outstanding at December 31, 2021 is as follows:


			Options Outstanding				Options Exercisable
Range of Exercise Prices ($)			Number	Weighted Average Exercise Price		Weighted Average Remaining Contractual Life (Years)	Number	Weighted Average Exercise Price		Weighted Average Remaining Contractual Life (Years)
$5.86	-	6.00	4,000	$	5.93	0.8	4,000	$	5.93	0.8
9.00			26,000	9.00		1.8	26,000	9.00		1.8
10.26	-	10.71	57,875	10.57		3.2	57,875	10.57		3.2
15.67	-	19.13	92,300	16.52		7.5	40,980	16.04		5.9
26.50	-	27.25	43,016	27.13		7.8	17,596	27.13		7.8
28.23	-	29.69	125,050	28.81		8.2	40,200	29.69		5.8
31.80			39,080	31.80		6.8	24,000	31.80		6.8
			387,321	$	21.70	6.6	210,651	$	18.80	4.8

The aggregate intrinsic value of options outstanding at December 31, 2021 and 2020 was $2.62 million and $2.88 million, respectively.

As of December 31, 2021, unrecognized compensation cost related to unvested stock options was $844,000, which is expected to be recognized over a weighted average life of 2.42 years.